• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

tumor

Mosaic pattern collage
Biotech

Mosaic licenses 2 clinical stage tumor drugs from Otsuka's Astex

Mosaic secured the latest pieces in its medicine combination strategy by licensing two clinical stage tumor drugs from fellow British biotech Astex
James Waldron Apr 24, 2025 10:00am
Three blocks displaying from left to right a person a handshake and another person

Merck KGaA pays $85M for global rights to Abbisko's tumor drug

Apr 1, 2025 7:40am
Abstract 3D Geometric Shapes Cube Blocks Background

Takeda's oncology execs sharpen focus after restructuring

Mar 13, 2025 10:59am
Graphic image of a fishing line looking to hook onto 100 bills underwater

Merck KGaA tacks on Abbisko’s joint tumor med for $70M upfront

Dec 4, 2023 10:26am
An arrow incrementally going up stairs before pointing straight up Blue background

Deciphera's tumor-tackling oral med achieves 40% response rate

Oct 30, 2023 11:00am
Zurich Switzerland

Racing Sanofi, ImmunOs bags $74M for myeloid checkpoint trials

Jun 7, 2022 8:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings